Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19". Davoudi-Monfared E, Khalili H. Antimicrob Agents Chemother 2021;65.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Davoudi-Monfared E, Khalili H. Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19". Antimicrob Agents Chemother 2021;65.
PMID: 33558288